These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36654616)

  • 1. Low-Dose Methotrexate Toxicity Presenting as Pancytopenia.
    Dhillon GS; Chauhan S; Jalal Y; Ghobrial Y; Ahmed B
    Cureus; 2022 Dec; 14(12):e32494. PubMed ID: 36654616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How should we manage low-dose methotrexate-induced pancytopenia in patients with rheumatoid arthritis?
    Cansu DÜ; Teke HÜ; Bodakçi E; Korkmaz C
    Clin Rheumatol; 2018 Dec; 37(12):3419-3425. PubMed ID: 30056523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose methotrexate toxicity leading to pancytopenia: leucovorin as a rescue treatment.
    Schelzel G; Palicherla A; Tauseef A; Millner P
    Proc (Bayl Univ Med Cent); 2024; 37(2):339-343. PubMed ID: 38343452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of pancytopenia secondary to low-dose pulse methotrexate therapy in a patient with rheumatoid arthritis and renal insufficiency.
    Park GT; Jeon DW; Roh KH; Mun HS; Lee CH; Park CH; Kang KW; Kim SM; Kang JM; Park HC
    Korean J Intern Med; 1999 Jan; 14(1):85-7. PubMed ID: 10063319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate and doxycycline interaction: a rare cause of pancytopenia.
    Arslan A; Zain MA; Mukhtar M; Ullah W; Roomi S
    BMJ Case Rep; 2019 May; 12(5):. PubMed ID: 31154348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early onset methotrexate-induced pancytopenia and response to G-CSF: a report of two cases.
    Yoon KH; Ng SC
    J Clin Rheumatol; 2001 Feb; 7(1):17-20. PubMed ID: 17039083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancytopenia as a Complication of Low-Dose Methotrexate in a Septuagenarian: A Rare Presentation.
    Kanderi T; Chan Gomez J; Puthenpura MM; Yarlagadda K; Gangireddy M
    Cureus; 2020 Jun; 12(6):e8492. PubMed ID: 32656010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early-onset pancytopenia and skin ulcer following low-dose methotrexate therapy.
    Hocaoglu N; Atilla R; Onen F; Tuncok Y
    Hum Exp Toxicol; 2008 Jul; 27(7):585-9. PubMed ID: 18829735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe Pancytopenia Following Single Dose Methotrexate In Psoriasis: A Rare And Potentially Lethal Manifestation.
    Singh A; Choudhary R; Chhabra N; Ganguly S; Rathore V
    Curr Drug Saf; 2021; 16(1):110-113. PubMed ID: 33106147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cotton wool spots as an indicator of methotrexate-induced blood dyscrasia.
    Klemencic S
    Optometry; 2010 Apr; 81(4):177-80. PubMed ID: 20346888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe pancytopenia associated with low-dose methotrexate therapy for rheumatoid arthritis.
    Calvo-Romero JM
    Ann Pharmacother; 2001 Dec; 35(12):1575-7. PubMed ID: 11793624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxic epidermal necrolysis following combination of methotrexate and trimethoprim-sulfamethoxazole.
    Yang CH; Yang LJ; Jaing TH; Chan HL
    Int J Dermatol; 2000 Aug; 39(8):621-3. PubMed ID: 10971734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate-induced renal impairment: clinical studies and rescue from systemic toxicity with high-dose leucovorin and thymidine.
    Abelson HT; Fosburg MT; Beardsley GP; Goorin AM; Gorka C; Link M; Link D
    J Clin Oncol; 1983 Mar; 1(3):208-16. PubMed ID: 6607976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and risk factors for low dose methotrexate toxicity: a cohort of 28 patients.
    Kivity S; Zafrir Y; Loebstein R; Pauzner R; Mouallem M; Mayan H
    Autoimmun Rev; 2014 Nov; 13(11):1109-13. PubMed ID: 25172240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Toxicity of low-dose methotrexate in rheumatoid arthritis--clinical characteristics in patients with MTX-induced pancytopenia and interstitial pneumonitis].
    Ohosone Y; Okano Y; Kameda H; Hama N; Matsumura M; Nojima T; Nakamura K; Kuwana M; Ogasawara T; Hirakata M; Yoshida T; Mimori T; Akizuki M; Ikeda Y
    Ryumachi; 1997 Feb; 37(1):16-23. PubMed ID: 9128419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weekly methotrexate-calcium leucovorin rescue: effect of alkalinization on nephrotoxicity; pharmacokinetics in the CNS; and use in CNS non-Hodgkin's lymphoma.
    Pitman SW; Frei E
    Cancer Treat Rep; 1977 Jul; 61(4):695-701. PubMed ID: 18282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis.
    Gutierrez-Ureña S; Molina JF; García CO; Cuéllar ML; Espinoza LR
    Arthritis Rheum; 1996 Feb; 39(2):272-6. PubMed ID: 8849378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperpigmentation, severe alopecia, and six days of instability in a case of severe methotrexate hypersensitivity reaction.
    Shafie M; Abbaszadeh M; Sharifi F
    Daru; 2021 Jun; 29(1):205-209. PubMed ID: 33409982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancytopenia associated with low dose pulse methotrexate in the treatment of rheumatoid arthritis.
    MacKinnon SK; Starkebaum G; Willkens RF
    Semin Arthritis Rheum; 1985 Nov; 15(2):119-26. PubMed ID: 3877983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancytopenia associated with low dose methotrexate therapy. A regional survey.
    al-Awadhi A; Dale P; McKendry RJ
    J Rheumatol; 1993 Jul; 20(7):1121-5. PubMed ID: 8371202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.